...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Announces Publication of its 40th Scientific Journal Article on Apabetalone's Potential Therapeutic Benefits

 ,,,Good greif,,we are still testing RVX-208 = Apabetalone in mouse models and in test tubes after 20 GD years!!...Its laughable but the reality is, its actually how pitiful our management team has been and remains so! Yet the granting of options and RSUs seem to be the only daily activity within!...

It amazes me where ZENE can attract such interest from big Pharma around oncology and we sit with some sort of molecule that seems to be worthy to humnaity and we are stagnated,,,becalmed,,,,and isolated from the investment world...with the team advancing nothing since the return of the BOM trial years ago!!..Ancient history of sorts!!,,Will it be 5 years this Fall since those results?,,,I think so!,How much incompentency can any invetsor handle!!,,I wonder if we have advanced the developement of epigenetics beyond the 8 years we supposedly had a decade ago???,,another tongue in cheek sales pitch from our symposium manager.

Share
New Message
Please login to post a reply